Genetic and Clinical Analyses of Spinocerebellar Ataxia Type 8 in Mainland China
Authors
Affiliations
Background: Spinocerebellar ataxia type 8 (SCA8) is a rare autosomal dominant neurodegenerative disease caused by CTA/CTG repeat expansion in the ATXN8/ATXN8OS gene.
Methods: To analyze the frequency and clinical characteristics of SCA8 patients in mainland China, we combined polymerase chain reaction (PCR) and triplet repeat-primed PCR (TRP-PCR) to detect the CTA/CTG expansion. We studied a cohort of 362 ataxia patients in which the other known causative genes had been previously excluded, from among 1294 index patients. Positive samples were validated by southern blotting.
Results: The CTA/CTG expansion was observed in six probands, accounting for approximately 0.46% (6/1294) in all patients, and 1.66% (6/362) in patients without definite molecular diagnosis. Clinically, aside from the typical SCA8 phenotype, some patients carrying the CTA/CTG expansion exhibited the cerebellar form of multisystem atrophy (MSA-C) and ataxia with paroxysmal kinesigenic dyskinesia (PKD).
Conclusion: For the first time, we described the PKD phenotype in association with CTA/CTG expansion, suggesting that CTA/CTG expansion might play a role in the pathogenesis of paroxysmal dyskinesia symptoms.
Tremor in Spinocerebellar Ataxia: A Scoping Review.
Mukherjee A, Pandey S Tremor Other Hyperkinet Mov (N Y). 2024; 14:31.
PMID: 38911333 PMC: 11192095. DOI: 10.5334/tohm.911.
Chen S, Li S, Liu Y, She R, Jiang W Front Hum Neurosci. 2023; 17:1198309.
PMID: 37529405 PMC: 10388100. DOI: 10.3389/fnhum.2023.1198309.
Spinocerebellar ataxia type 8 presents as progressive supranuclear palsy.
Jiang L, Zhu W, Zhao G, Cao L Neurosciences (Riyadh). 2023; 28(3):199-203.
PMID: 37482381 PMC: 10519649. DOI: 10.17712/nsj.2023.3.20230032.
A Review of Ocular Movement Abnormalities in Hereditary Cerebellar Ataxias.
Salari M, Etemadifar M, Rashedi R, Mardani S Cerebellum. 2023; 23(2):702-721.
PMID: 37000369 DOI: 10.1007/s12311-023-01554-0.
Perez B, Shorrock H, Banez-Coronel M, Zu T, Romano L, Laboissonniere L EMBO Mol Med. 2021; 13(11):e14095.
PMID: 34632710 PMC: 8573593. DOI: 10.15252/emmm.202114095.